Table 3.
Unadjusted and adjusted effect of mesh-augmentation on important outcome variables
| Unadjusted | p | Adjusted | p | |
|---|---|---|---|---|
| Odds ratio (95% CI) | Odds ratio (95% CI) | |||
| In-hospital mortality | ||||
| VAC-IPOM | 0.76 (0.32–1.82) | 0.534 | 0.45 (0.13–1.61) | 0.221 |
| ASA score > 3 | 2.56 (1.02–6.42) | 0.045 | 3.92 (1.08–14.23) | 0.038 |
| Emergency primary procedure | 2.04 (0.88–4.71) | 0.097 | 3.60 (1.13–11.44) | 0.030 |
| Immunosuppressive drugs | 4.72 (1.54–14.46) | 0.006 | 5.14 (1.43–18.44) | 0.012 |
| Unadjusted | p | Adjusted | p | |
|---|---|---|---|---|
| Odds ratio (95% CI) | Odds ratio (95% CI) | |||
| Intestinal fistula at 100 days | ||||
| VAC-IPOM | 1.29 (0.54–3.04) | 0.566 | 2.06 (0.78–5.42) | 0.143 |
| ASA score > 3 | 0.26 (0.05–1.02) | 0.052 | 0.19 (0.04–0.97) | 0.045 |
| Emergency primary procedure | 0.38 (0.15–0.94) | 0.035 | 0.47 (0.18–1.20) | 0.114 |
| Unadjusted | p | Adjusted | p | |
|---|---|---|---|---|
| Hazard ratio (95% CI) | Hazard ratio (95% CI) | |||
| Hernia-free survival | ||||
| VAC-IPOM | 0.30 (0.09–1.02) | 0.055 | 0.36 (0.10–1.27) | 0.114 |
| Immunosuppressive drugs | 3.02 (0.87–10.5) | 0.083 | 2.74 (0.78–9.64) | 0.116 |
| Age | 0.97 (0.94–1.00) | 0.078 | 0.97 (0.94–1.01) | 0.126 |
| Unadjusted | p | Adjusted | p | |
|---|---|---|---|---|
| Hazard ratio (95% CI) | Hazard ratio (95% CI) | |||
| Duration of stay on Intensive care unit | ||||
| VAC-IPOM | 0.52 (0.36–0.77) | < 0.001 | 0.53 (0.36–0.79) | 0.002 |
| Emergency primary procedure | 1.26 (0.89–1.78) | 0.193 | 1.29 (0.88–1.89) | 0.198 |
| Immunosuppressive drugs | 1.67 (0.97–2.90) | 0.066 | 1.38 (0.79–2.43) | 0.257 |
| Age | 1.01 (1.00–1.03) | 0.034 | 1.01 (1.00–1.03) | 0.109 |
| Malignancy | 0.67 (0.47–0.95) | 0.026 | 0.77 (0.53–1.13) | 0.189 |
| Unadjusted | p | Adjusted | p | |
|---|---|---|---|---|
| Hazard ratio (95% CI) | Hazard ratio (95% CI) | |||
| Duration of hospital stay | ||||
| VAC-IPOM | 0.57 (0.38–0.87) | 0.008 | 0.61 (0.40–0.94) | 0.024 |
| Age | 1.02 (1.00–1.03) | 0.029 | 1.01 (1.00–1.03) | 0.115 |
| Malignancy | 0.74 (0.49–1.01) | 0.138 | 0.86 (0.58–1.30) | 0.484 |
| Unadjusted | p | Adjusted | p | |
|---|---|---|---|---|
| Incidence risk ratio (95% CI) | Incidence risk ratio (95% CI) | |||
| Re-operations during OA treatment | ||||
| VAC-IPOM | 0.49 (0.41–0.58) | < 0.001 | 0.48 (0.39–0.58) | < 0.001 |
| ASA Score > 3 | 0.70 (0.57–0.85) | < 0.001 | 1.04 (0.82–1.32) | 0.755 |
| Emergency primary procedure | 0.89 (0.78–1.02) | 0.090 | 0.89 (0.76–1.04) | 0.134 |
| Age | 0.99 (0.99–0.99) | < 0.001 | 1.00 (0.99–1.00) | 0.345 |
| Malignancy | 0.69 (0.60–0.79) | < 0.001 | 0.75 (0.64–0.89) | < 0.001 |
| BMI | 1.00 (1.00–1.01) | 0.117 | 1.01 (1.00–1.01) | 0.016 |
| Male gender | 0.81 (0.71–0.92) | 0.001 | 0.90 (0.78–1.04) | 0.151 |
Odds ratios, hazard ratios and incidence risk ratios are shown VAC-IPOM versus VAWCM. Variables with a p value below 0.2 on univariable analysis are displayed
Bold values are considered significant (p < 0.05)
95% CI 95% confidence interval; ASA American Society of Anaesthesiology